Revelations Partners, LP

Revelations Partners, LP is a single-family office investment firm.

Opinions are our own and not investment advice.

[Revelations Partners, LP @RevelationsLP]

@AggieCapitalist Any sense to what the issue is here other than general market apathy for payments/software/value still?

[Revelations Partners, LP @RevelationsLP]

@calvinfroedge @mohamedmebarki7 Isn't the key missing piece here that Google is choosing to spend this CapEx because it sees attractive opportunities ahead which is appearing via massive growth and margin expansion? Why is it obvious that it is a bad deal?

[Revelations Partners, LP @RevelationsLP]

Pretty clear the market still isn’t fully appreciating the financial discipline at $GTBIF and $CXXIF. As the cannabis industry matures, balance sheet strength and disciplined capital allocation should matter a lot more.

[Sammy J @sammyj_19]

$MSOS with:

a) no net debt (ex. UTP)

b) positive Earnings Before Tax TTM

c) positive free cash flow TTM

d) revenue per share growth TTM

e) less shares out today than at all-time highs Feb.'21

f) all of the above = 1. $GTBIF 2. $CXXIF

source: SSC👇 & Company filings

[Revelations Partners, LP @RevelationsLP]

@V_arrell Agreed. Lots of integration risk here. Will be a bit skeptical until proven otherwise.

[Revelations Partners, LP @RevelationsLP]

@orrdavid When market participants are making money hand over fist in semis and AI, there’s very little appetite for value, quality, or low-volatility stocks.

[Revelations Partners, LP @RevelationsLP]

If $TSLA can trade at 120x T12M EBITDA I'm sure SpaceX can trade for an absurd valuation too.

[James Chanos @RealJimChanos]

SpaceX Adjusted EBITDA Table

[Revelations Partners, LP @RevelationsLP]

@evfcfaddict Biggest headwind is rates. Building Envelope sensitive to resi construction and that continues to be elusive. Otherwise great assets and long-term potential.

[Revelations Partners, LP @RevelationsLP]

@AggieCapitalist Seems like housing and building materials getting hurt from rising rates but rest of the market unaffected?

[Revelations Partners, LP @RevelationsLP]

@CannaVestments @DenisRudev They also have two semi-annual interest payments vs. quarterly so that has an impact as well. Not saying it would have been a huge positive number but some puts and takes to consider.

[Revelations Partners, LP @RevelationsLP]

@CannaVestments @DenisRudev To be fair, that was mostly in part due to one-time arbitration payment.

[Revelations Partners, LP @RevelationsLP]

@tomicki Interesting. What exactly is the market pricing in here? AI disruption risk? A broader multiple reset? The stock is down 40% over the past five years, which feels surprising for a business of this quality. What’s the bear case investors are underwriting?

[Revelations Partners, LP @RevelationsLP]

Since $VREOF announced its recap in Dec ’24, shares are down ~30% vs. +35% for $MSOS. The roll-up hasn’t resonated with the market, and lock-up expirations still lie ahead.

https://t.co/jakwcFfme0

[Revelations Partners, LP @RevelationsLP]

@MrMojoRisinX $SHC has been a casualty of broader medical device apathy, but this should at least remove one overhang on the stock.

[Revelations Partners, LP @RevelationsLP]

@AggieCapitalist Brutal market to be a value investor in.

[Revelations Partners, LP @RevelationsLP]

@AggieCapitalist Very interesting!

[Revelations Partners, LP @RevelationsLP]

@AggieCapitalist Wild. Hard to be a value investor these days.

[Revelations Partners, LP @RevelationsLP]

@SowingAlphaSeed Got it. Thank you. Fortunately, I was in $FLYW. Only wish I was in $EVC.

[Revelations Partners, LP @RevelationsLP]

@srg444 And they are actually reducing share count, not just making up for SBC.